BELLEVUE GROUP AG – Fate Therapeutics, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$83.95M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
-9.56%
quarter
Fate Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +5.52% | 196K shares | -4.02M | $22.41 | 3.74M |
| Q2 2022 | share | Decrease | -0.74% | -26.4K shares | -50.68M | $24.78 | 3.55M |
| Q1 2022 | share | Decrease | -5.28% | -199.25K shares | -82.25M | $38.77 | 3.57M |
| Q4 2021 | share | Increase | +16.61% | 537.7K shares | 29M | $60.07 | 3.77M |
| Q3 2021 | share | Increase | +23.89% | 624.5K shares | -34.91M | $59.27 | 3.23M |
| Q2 2021 | share | Increase | +18.30% | 404.2K shares | 44.66M | $86.79 | 2.61M |
| Q1 2021 | share | Increase | +4.83% | 101.83K shares | -9.47M | $82.45 | 2.20M |
| Q4 2020 | share | Decrease | -4.96% | -110K shares | 103.00M | $90.93 | 2.10M |
| Q3 2020 | share | Increase | +13.06% | 256.1K shares | 21.33M | $39.97 | 2.21M |
| Q2 2020 | share | Increase | +25.47% | 398.2K shares | 32.57M | $34.31 | 1.96M |
| Q1 2020 | share | Increase | +1787.92% | 1.48M shares | 33.09M | $22.21 | 1.56M |
| Q4 2019 | share | Increase | +37.77% | 22.7K shares | 687K | $19.57 | 82.8K |
| Q3 2019 | share | Increase | +1.86% | 1.1K shares | -265K | $15.53 | 60.1K |
| Q2 2019 | share | Increase | 0.00% | 59K shares | 1.19M | $20.3 | 59K |